Seres Therapeutics Stock Price History
| MCRB Stock | USD 0.98 0.06 6.52% |
Below is the normalized historical share price chart for Seres Therapeutics extending back to June 26, 2015. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Seres Therapeutics stands at 0.98, as last reported on the 1st of December, with the highest price reaching 0.99 and the lowest price hitting 0.94 during the day.
If you're considering investing in Seres Stock, it is important to understand the factors that can impact its price. Seres Therapeutics appears to be very risky, given 3 months investment horizon. Seres Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0859, which indicates the firm had a 0.0859% return per unit of risk over the last 3 months. By inspecting Seres Therapeutics' technical indicators, you can evaluate if the expected return of 0.57% is justified by implied risk. Please review Seres Therapeutics' Coefficient Of Variation of 1318.51, semi deviation of 5.62, and Risk Adjusted Performance of 0.0668 to confirm if our risk estimates are consistent with your expectations.
At present, Seres Therapeutics' Common Stock Shares Outstanding is projected to increase significantly based on the last few years of reporting. The current year's Common Stock is expected to grow to about 141.8 K, whereas Total Stockholder Equity is projected to grow to (42.6 M). . As of December 1, 2024, Price To Sales Ratio is expected to decline to 1.35. In addition to that, Price Earnings Ratio is expected to decline to -1.65. Seres Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 26th of June 2015 | 200 Day MA 0.8967 | 50 Day MA 0.8106 | Beta 2.05 |
Seres |
Sharpe Ratio = 0.0859
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | MCRB | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 6.69 actual daily | 59 59% of assets are less volatile |
Expected Return
| 0.57 actual daily | 11 89% of assets have higher returns |
Risk-Adjusted Return
| 0.09 actual daily | 6 94% of assets perform better |
Based on monthly moving average Seres Therapeutics is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Seres Therapeutics by adding it to a well-diversified portfolio.
Price Book 6.9954 | Enterprise Value Ebitda (2.07) | Price Sales 1.3245 | Shares Float 98.6 M | Wall Street Target Price 3.874 |
Seres Therapeutics Stock Price History Chart
There are several ways to analyze Seres Stock price data. The simplest method is using a basic Seres candlestick price chart, which shows Seres Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | September 23, 2024 | 1.16 |
| Lowest Price | November 15, 2024 | 0.55 |
Seres Therapeutics December 1, 2024 Stock Price Synopsis
Various analyses of Seres Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Seres Stock. It can be used to describe the percentage change in the price of Seres Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Seres Stock.| Seres Therapeutics Price Daily Balance Of Power | 1.20 | |
| Seres Therapeutics Price Action Indicator | 0.04 | |
| Seres Therapeutics Price Rate Of Daily Change | 1.07 |
Seres Therapeutics December 1, 2024 Stock Price Analysis
Seres Stock Price History Data
The price series of Seres Therapeutics for the period between Mon, Sep 2, 2024 and Sun, Dec 1, 2024 has a statistical range of 0.61 with a coefficient of variation of 16.18. The daily prices for the period are spread out with arithmetic mean of 0.84. The median price for the last 90 days is 0.82.| Open | High | Low | Close | Volume | ||
12/01/2024 | 0.95 | 0.99 | 0.94 | 0.98 | ||
| 11/29/2024 | 0.95 | 0.99 | 0.94 | 0.98 | 3,585,585 | |
| 11/27/2024 | 0.88 | 0.93 | 0.86 | 0.92 | 1,663,547 | |
| 11/26/2024 | 0.96 | 0.96 | 0.80 | 0.88 | 2,879,577 | |
| 11/25/2024 | 0.79 | 0.90 | 0.77 | 0.89 | 6,772,012 | |
| 11/22/2024 | 0.75 | 0.78 | 0.72 | 0.77 | 1,581,745 | |
| 11/21/2024 | 0.83 | 0.88 | 0.72 | 0.73 | 4,167,572 | |
| 11/20/2024 | 0.68 | 0.88 | 0.67 | 0.81 | 12,200,605 | |
| 11/19/2024 | 0.58 | 0.70 | 0.58 | 0.69 | 4,400,637 | |
| 11/18/2024 | 0.54 | 0.62 | 0.54 | 0.58 | 3,368,645 | |
| 11/15/2024 | 0.60 | 0.60 | 0.55 | 0.55 | 3,482,903 | |
| 11/14/2024 | 0.59 | 0.61 | 0.58 | 0.59 | 2,013,291 | |
| 11/13/2024 | 0.65 | 0.69 | 0.59 | 0.59 | 5,437,302 | |
| 11/12/2024 | 0.69 | 0.71 | 0.63 | 0.66 | 3,470,811 | |
| 11/11/2024 | 0.74 | 0.76 | 0.69 | 0.69 | 2,440,411 | |
| 11/08/2024 | 0.70 | 0.73 | 0.70 | 0.72 | 1,680,486 | |
| 11/07/2024 | 0.75 | 0.76 | 0.71 | 0.72 | 2,171,876 | |
| 11/06/2024 | 0.84 | 0.84 | 0.74 | 0.76 | 1,658,131 | |
| 11/05/2024 | 0.79 | 0.82 | 0.76 | 0.81 | 1,389,461 | |
| 11/04/2024 | 0.83 | 0.85 | 0.79 | 0.81 | 1,711,022 | |
| 11/01/2024 | 0.79 | 0.83 | 0.79 | 0.82 | 2,243,950 | |
| 10/31/2024 | 0.78 | 0.83 | 0.76 | 0.82 | 2,302,197 | |
| 10/30/2024 | 0.76 | 0.81 | 0.75 | 0.78 | 1,999,941 | |
| 10/29/2024 | 0.71 | 0.79 | 0.71 | 0.77 | 4,364,388 | |
| 10/28/2024 | 0.69 | 0.76 | 0.69 | 0.70 | 2,519,034 | |
| 10/25/2024 | 0.72 | 0.75 | 0.68 | 0.70 | 2,245,653 | |
| 10/24/2024 | 0.76 | 0.77 | 0.71 | 0.71 | 2,973,668 | |
| 10/23/2024 | 0.77 | 0.80 | 0.75 | 0.76 | 1,527,830 | |
| 10/22/2024 | 0.81 | 0.83 | 0.78 | 0.78 | 927,238 | |
| 10/21/2024 | 0.85 | 0.85 | 0.81 | 0.81 | 929,853 | |
| 10/18/2024 | 0.85 | 0.86 | 0.83 | 0.85 | 794,269 | |
| 10/17/2024 | 0.82 | 0.87 | 0.82 | 0.84 | 962,386 | |
| 10/16/2024 | 0.81 | 0.86 | 0.81 | 0.84 | 1,248,577 | |
| 10/15/2024 | 0.83 | 0.85 | 0.81 | 0.82 | 1,204,797 | |
| 10/14/2024 | 0.79 | 0.86 | 0.79 | 0.84 | 1,963,020 | |
| 10/11/2024 | 0.77 | 0.82 | 0.77 | 0.81 | 3,869,222 | |
| 10/10/2024 | 0.74 | 0.85 | 0.70 | 0.77 | 9,638,118 | |
| 10/09/2024 | 0.76 | 0.79 | 0.73 | 0.74 | 3,811,410 | |
| 10/08/2024 | 0.82 | 0.84 | 0.75 | 0.77 | 4,766,736 | |
| 10/07/2024 | 0.84 | 0.87 | 0.82 | 0.83 | 1,712,924 | |
| 10/04/2024 | 0.85 | 0.86 | 0.83 | 0.85 | 2,160,067 | |
| 10/03/2024 | 0.85 | 0.90 | 0.84 | 0.84 | 3,307,185 | |
| 10/02/2024 | 0.93 | 0.95 | 0.87 | 0.90 | 2,599,886 | |
| 10/01/2024 | 0.82 | 0.97 | 0.80 | 0.96 | 9,458,996 | |
| 09/30/2024 | 0.97 | 1.07 | 0.94 | 0.95 | 6,922,463 | |
| 09/27/2024 | 0.87 | 1.01 | 0.84 | 0.92 | 11,934,734 | |
| 09/26/2024 | 0.98 | 0.98 | 0.80 | 0.83 | 10,660,503 | |
| 09/25/2024 | 1.09 | 1.10 | 0.91 | 0.92 | 11,999,635 | |
| 09/24/2024 | 1.14 | 1.16 | 1.10 | 1.11 | 3,530,329 | |
| 09/23/2024 | 1.13 | 1.21 | 1.10 | 1.16 | 5,187,374 | |
| 09/20/2024 | 1.02 | 1.13 | 1.00 | 1.13 | 6,397,477 | |
| 09/19/2024 | 1.09 | 1.10 | 1.02 | 1.05 | 2,506,652 | |
| 09/18/2024 | 1.10 | 1.13 | 1.04 | 1.05 | 2,887,185 | |
| 09/17/2024 | 1.03 | 1.14 | 1.02 | 1.10 | 4,349,197 | |
| 09/16/2024 | 0.99 | 1.07 | 0.98 | 1.02 | 2,596,387 | |
| 09/13/2024 | 0.94 | 1.00 | 0.91 | 1.00 | 3,071,475 | |
| 09/12/2024 | 1.10 | 1.20 | 0.92 | 0.96 | 8,082,896 | |
| 09/11/2024 | 1.03 | 1.08 | 1.00 | 1.05 | 1,823,619 | |
| 09/10/2024 | 1.03 | 1.07 | 0.97 | 1.03 | 3,285,415 | |
| 09/09/2024 | 0.96 | 1.11 | 0.91 | 1.03 | 5,793,053 | |
| 09/06/2024 | 0.91 | 1.32 | 0.86 | 0.95 | 24,791,418 |
About Seres Therapeutics Stock history
Seres Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Seres is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Seres Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Seres Therapeutics stock prices may prove useful in developing a viable investing in Seres Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 128 M | 134.4 M | |
| Net Loss | -225.1 M | -213.9 M |
Seres Therapeutics Quarterly Net Working Capital |
|
Seres Therapeutics Stock Technical Analysis
Seres Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Watchlist Optimization Now
Watchlist OptimizationOptimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |
| All Next | Launch Module |
Seres Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Seres Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Seres Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Seres to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0668 | |||
| Jensen Alpha | 0.4493 | |||
| Total Risk Alpha | (0.61) | |||
| Sortino Ratio | 0.0552 | |||
| Treynor Ratio | 1.5 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Seres Stock analysis
When running Seres Therapeutics' price analysis, check to measure Seres Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Seres Therapeutics is operating at the current time. Most of Seres Therapeutics' value examination focuses on studying past and present price action to predict the probability of Seres Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Seres Therapeutics' price. Additionally, you may evaluate how the addition of Seres Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |